Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis.

Competing Interests: Conflict of interest: K-H. Schmidt has received fees for lectures and educational events from Abbott, Janssen and MSD. K. Milger has received fees from Actelion, AstraZeneca, GSK, Janssen, MSD, Novartis and Sanofi-Avensis. C. Pausch has no disclosures. D. Huscher has received travel compensation from Shire. D. Pittrow has received fees for consultations from Actelion, Amgen, Aspen, Bayer, Biogen, Boehringer Ingelheim, Daiichi Sankyo, MSD, Novartis, Sanofi-Genzyme, Takeda, Viatris and Zambon. E. Grünig has received fees for lectures and/or consultations from Actelion, Bayer, Ferrer, GSK, Janssen, MSD and Orpha Care. G. Staehler has received honoraria for lectures and/or consultancy for Actelion, Bayer, GSK, Novartis and Pfizer. H. Gall reports personal fees from Actelion, AstraZeneca, Bayer, BMS, GossamerBio, GSK, Janssen-Cilag, Lilly, MSD, Novartis, OMT, Pfizer and United Therapeutics. O. Distler has/had consultancy relationship and/or has received research funding from 4 D Science, Actelion, Active Biotec, Bayer, Biogen Idec, Boehringer Ingelheim Pharma, BMS, ChemoAb, EpiPharm, Ergonex, espeRare foundation, GSK, Genentech/Roche, Inventiva, Janssen, Lilly, medac, MedImmune, Mitsubishi Tanabe, Pharmacyclics, Pfizer, Sanofi, Serodapharm and Sinoxa in the area of potential treatments of scleroderma and its complications, including PAH; and in addition, has a patent mir-29 for the treatment of systemic sclerosis licensed. D. Skowasch received fees for lectures and/or consulting and/or research support to institution from Actelion, Bayer, GSK, Janssen, MSD and Pfizer. M. Halank has received speaker fees and honoraria for consultations from Acceleron, Actelion, AstraZeneca, BerlinChemie, GSK, Janssen and MSD. H. Wilkens received fees for lectures and/or consultations from Actelion, Bayer, Biotest, Boehringer, GSK, Janssen, MSD, Pfizer and Roche. M. Held has received speaker fees and honoraria for consultations from Actelion, Bayer, Boehringer Ingelheim Pharma, GlaxoSmithKline, Janssen, MSD, Novartis, Pfizer, Nycomed, Roche and Servier. H. Klose has received speaker fees and honoraria for consultations from Actelion, Bayer, GSK, Janssen, MSD, Novartis, Pfizer and United Therapeutics. M.M. Hoeper has received fees for lectures and/or consultations from Acceleron, Actelion, AOP Health, Bayer, Ferrer, GSK, Janssen, MSD and Pfizer.